These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 12389075
1. The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats. Hamar P, Szabó A, Müller V, Heemann U. Transpl Int; 2002 Oct; 15(9-10):446-54. PubMed ID: 12389075 [Abstract] [Full Text] [Related]
2. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model. Lutz J, Huang H, Deng M, Wagner B, Roos M, Schmaderer C, Strobl M, Heemann U. Transplantation; 2007 Mar 27; 83(6):741-6. PubMed ID: 17414707 [Abstract] [Full Text] [Related]
3. Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U. Transpl Int; 2002 Oct 27; 15(9-10):494-501. PubMed ID: 12389082 [Abstract] [Full Text] [Related]
4. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M. J Surg Res; 2007 Dec 27; 143(2):428-36. PubMed ID: 17628598 [Abstract] [Full Text] [Related]
7. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation. Savikko J, Rintala J, von Willebrand E. Transplant Proc; 2006 Dec 27; 38(10):3231-2. PubMed ID: 17175231 [Abstract] [Full Text] [Related]
8. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta. Rintala JM, Savikko J, Rintala SE, von Willebrand E. Transplant Proc; 2006 Oct 27; 38(8):2719-21. PubMed ID: 17098049 [Abstract] [Full Text] [Related]
9. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts. Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH. Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186 [Abstract] [Full Text] [Related]
11. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof]. Zou HQ, Yao J, Wang YX, Wang J, Li D, Wang P. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):981-5. PubMed ID: 16061007 [Abstract] [Full Text] [Related]
12. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy. Savikko J, Taskinen E, Von Willebrand E. Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194 [Abstract] [Full Text] [Related]
15. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ. J Surg Res; 2009 Nov 27; 157(1):e117-27. PubMed ID: 19589538 [Abstract] [Full Text] [Related]
20. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J. Transplant Proc; 2008 Dec 27; 40(10):3731-6. PubMed ID: 19100477 [Abstract] [Full Text] [Related] Page: [Next] [New Search]